Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

22/09/2026

Attivazione web e pubblicazione schede di monitoraggio – Registro QALSODY

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

14/09/2026

Newsletter Disuguaglianze di salute n.56

Agendas and minutes

22/09/2026

Agenda of the HMPC meeting 22-24 September 2026

Consumer Updates RSS Feed

15/09/2026

The Facts on Tampons and Tampon Safety

Regulatory and procedural guidelines (human and veterinary)

18/09/2026

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Scientific guidelines (human and veterinary)

21/09/2026

ICH M13B guideline on bioequivalence for immediate-release solid oral dosage forms - additional strengths biowaiver - Step 5

Paediatric investigation plans

04/09/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyclarys, omaveloxolone, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000338563

Orphan designations

26/08/2026

Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn

New medicines and opinions: human

18/09/2026

Human medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: Opinion

MedWatch Safety Alerts RSS Feed

21/09/2026

Convenience Kit Correction: AVID Medical Issues Correction for Kits Containing Huons Sodium Chloride Ampules

What's New: Drugs RSS Feed

22/09/2026

Innovative Science and Technology Approaches for New Drugs (ISTAND) Program

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis